PMV Pharmaceuticals PMVP Stock
$1.16
-1.694914%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$61.86M
LOW - HIGH [24H]
$1.15
-
$1.19
VOLUME [24H]
$269.88K
P/E Ratio
0
Earnings per share
-$1.48
ISIN
US69353Y1038
PMV Pharmaceuticals Price Chart
PMV Pharmaceuticals PMVP Financial and Trading Overview
| PMV Pharmaceuticals stock price | 1.16 USD |
| Previous Close | 1.2 USD |
| Open | 1.2 USD |
| Bid | 0.89 USD x 200 |
| Ask | 1.53 USD x 200 |
| Day's Range | 1.18 - 1.25 USD |
| 52 Week Range | 0.9 - 1.88 USD |
| Volume | 442.65K USD |
| Avg. Volume | 447.11K USD |
| Market Cap | 65.6M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.48 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.33 USD |
PMVP Valuation Measures
| Enterprise Value | -27657928 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.1250035 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6265919 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.331 |
Trading Information
PMV Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 33.84% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1.88 USD |
| 52 Week Low | 0.9 USD |
| 50-Day Moving Average | 1.35 USD |
| 200-Day Moving Average | 1.33 USD |
PMVP Share Statistics
| Avg. Volume (3 month) | 447.11K USD |
| Avg. Daily Volume (10-Days) | 323.13K USD |
| Shares Outstanding | 53.33M |
| Float | 43.14M |
| Short Ratio | 7.28 |
| % Held by Insiders | 3.34% |
| % Held by Institutions | 69.51% |
| Shares Short | 3.08M |
| Short % of Float | 5.97% |
| Short % of Shares Outstanding | 5.78% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -39.14% |
| Return on Equity (ttm) | -63.16% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -83531000 USD |
| Net Income Avi to Common (ttm) | -78344000 USD |
| Diluted EPS (ttm) | -1.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 93.55M USD |
| Total Cash Per Share (mrq) | 1.75 USD |
| Total Debt (mrq) | 293K USD |
| Total Debt/Equity (mrq) | 0.33 USD |
| Current Ratio (mrq) | 11.144 |
| Book Value Per Share (mrq) | 1.963 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -74990000 USD |
| Levered Free Cash Flow (ttm) | -47069000 USD |
Profile of PMV Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Princeton |
| Address | 400 Alexander Park Drive |
| ZIP | 08540 |
| Phone | 609 642 6670 |
| Website | https://www.pmvpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 54 |
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Q&A For PMV Pharmaceuticals Stock
What is a current PMVP stock price?
PMV Pharmaceuticals PMVP stock price today per share is 1.16 USD.
How to purchase PMV Pharmaceuticals stock?
You can buy PMVP shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PMV Pharmaceuticals?
The stock symbol or ticker of PMV Pharmaceuticals is PMVP.
Which industry does the PMV Pharmaceuticals company belong to?
The PMV Pharmaceuticals industry is Biotechnology.
How many shares does PMV Pharmaceuticals have in circulation?
The max supply of PMV Pharmaceuticals shares is 53.33M.
What is PMV Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
PMV Pharmaceuticals PE Ratio is now.
What was PMV Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
PMV Pharmaceuticals EPS is -1.48 USD over the trailing 12 months.
Which sector does the PMV Pharmaceuticals company belong to?
The PMV Pharmaceuticals sector is Healthcare.
PMV Pharmaceuticals PMVP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Select Market Com NQGS | 13180.97 USD — |
-0.87
|
— — | 13139.79 USD — | 13316.81 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}